Cargando…
A Novel Prognostic Biomarker Panel for Early-Stage Colon Carcinoma
SIMPLE SUMMARY: Decision about treatment choice in early-stage colon cancer may be difficult for clinicians because of a lack of published data. Colon cancer is a very heterogeneous disease, but some previous efforts have helped us elucidate potential biomarkers for characterizing patients. Our goal...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656725/ https://www.ncbi.nlm.nih.gov/pubmed/34885019 http://dx.doi.org/10.3390/cancers13235909 |